首页 > 最新文献

Advanced biology最新文献

英文 中文
New-QiangGuYin-Containing Serum Inhibits Osteoclast-Derived Exosome Secretion and Down-Regulates Notum to Promote Osteoblast Differentiation. 含新陈代谢抑制剂的血清可抑制破骨细胞分泌外泌体并下调Notum以促进成骨细胞分化
IF 3.2 3区 生物学 Q3 MATERIALS SCIENCE, BIOMATERIALS Pub Date : 2024-06-27 DOI: 10.1002/adbi.202400166
Shilong Meng, Xu Zhang, Yang Yu, Minghao Tong, Yifeng Yuan, Yanguang Cao, Wei Zhang, Xiaolin Shi, Kang Liu

New-QiangGuYin (N-QGY), the addition of sea buckthorn on the basis of QGY formula, is herbal formula widely used clinically in China for the treatment of osteoporosis (OP), but its mechanism warrants further exploration. The mechanisms of QGY and N-QGY in the treatment of OP are probed from the perspective of osteoclast-osteoblast balance. Thirty Sprague-Dawley rats are randomly divided into N-QGY group, QGY group, and Control group. Beyond control rats that orally took normal saline, other rats are orally administered with isometric N-QGY or QGY twice every day for 3 days. The drug-containing serum and control serum are prepared and their effects on osteoclast-derived exosome secretion are determined by bicinchoninic acid assay (BCA), nanoparticle tracking analysis, and Western blot. GW4869 and Interleukin-1β (IL-1β) are adopted as the exosome inhibitor and inducer, respectively. Exosome uptake, cell counting kit-8, alkaline phosphatase (ALP) staining, alizarin red staining, enzyme-linked immunosorbent assay, quantitative real-time polymerase chain reaction, and Western blot are performed to examine the effects of altered osteoclast exosome content on osteogenic differentiation of mesenchymal stem cells (MSCs). N-QGY, QGY, and GW4869 inhibit osteoclast-derived exosome secretion and exosome uptake by MSCs, whereas IL-1β exerted the opposite effects (p < 0.05). Different from IL-1β, N-QGY, QGY, and GW4869 partially elevated MSC viability, osteocalcin secretion, ALP, RUNX Family Transcription Factor 2 (RUNX2) and Osteopontin (OPN) expressions, and calcium deposition in the osteoclast-MSCs coculture system (p < 0.05). Mechanically, osteoclasts increased Notum protein level but decreased β-catenin level, which is enhanced by IL-1β but is reversed by GW4869, QGY, and N-QGY (p < 0.05). And the effect of N-QGY is more conspicuous than that of QGY (P<0.05). N-QGY-containing serum inhibits exosome levels in osteoclasts, thereby enhancing osteogenic differentiation of MSCs via inhibition of Notum protein and promotion of β-catenin protein.

新羌活汤(New-QiangGuYin,N-QGY)是在羌活汤基础上加入沙棘的中药方剂,是中国临床上广泛用于治疗骨质疏松症(OP)的中药方剂,但其作用机制有待进一步探讨。本研究从破骨细胞-成骨细胞平衡的角度探讨了 QGY 和 N-QGY 治疗 OP 的机制。30 只 Sprague-Dawley 大鼠被随机分为 N-QGY 组、QGY 组和对照组。除口服生理盐水的对照组大鼠外,其他大鼠均口服等量 N-QGY 或 QGY,每天两次,连续 3 天。制备含药血清和对照血清,并通过双喹啉酸测定法(BCA)、纳米颗粒追踪分析法和 Western 印迹法测定其对破骨细胞外泌体分泌的影响。GW4869和白细胞介素-1β(IL-1β)分别作为外泌体抑制剂和诱导剂。通过外泌体摄取、细胞计数试剂盒-8、碱性磷酸酶(ALP)染色、茜素红染色、酶联免疫吸附试验、实时定量聚合酶链反应和 Western 印迹等方法,研究破骨细胞外泌体含量的改变对间充质干细胞(MSCs)成骨分化的影响。N-QGY、QGY 和 GW4869 可抑制破骨细胞源性外泌体的分泌和间充质干细胞对外泌体的吸收,而 IL-1β 则产生相反的作用(p<0.05)。
{"title":"New-QiangGuYin-Containing Serum Inhibits Osteoclast-Derived Exosome Secretion and Down-Regulates Notum to Promote Osteoblast Differentiation.","authors":"Shilong Meng, Xu Zhang, Yang Yu, Minghao Tong, Yifeng Yuan, Yanguang Cao, Wei Zhang, Xiaolin Shi, Kang Liu","doi":"10.1002/adbi.202400166","DOIUrl":"https://doi.org/10.1002/adbi.202400166","url":null,"abstract":"<p><p>New-QiangGuYin (N-QGY), the addition of sea buckthorn on the basis of QGY formula, is herbal formula widely used clinically in China for the treatment of osteoporosis (OP), but its mechanism warrants further exploration. The mechanisms of QGY and N-QGY in the treatment of OP are probed from the perspective of osteoclast-osteoblast balance. Thirty Sprague-Dawley rats are randomly divided into N-QGY group, QGY group, and Control group. Beyond control rats that orally took normal saline, other rats are orally administered with isometric N-QGY or QGY twice every day for 3 days. The drug-containing serum and control serum are prepared and their effects on osteoclast-derived exosome secretion are determined by bicinchoninic acid assay (BCA), nanoparticle tracking analysis, and Western blot. GW4869 and Interleukin-1β (IL-1β) are adopted as the exosome inhibitor and inducer, respectively. Exosome uptake, cell counting kit-8, alkaline phosphatase (ALP) staining, alizarin red staining, enzyme-linked immunosorbent assay, quantitative real-time polymerase chain reaction, and Western blot are performed to examine the effects of altered osteoclast exosome content on osteogenic differentiation of mesenchymal stem cells (MSCs). N-QGY, QGY, and GW4869 inhibit osteoclast-derived exosome secretion and exosome uptake by MSCs, whereas IL-1β exerted the opposite effects (p < 0.05). Different from IL-1β, N-QGY, QGY, and GW4869 partially elevated MSC viability, osteocalcin secretion, ALP, RUNX Family Transcription Factor 2 (RUNX2) and Osteopontin (OPN) expressions, and calcium deposition in the osteoclast-MSCs coculture system (p < 0.05). Mechanically, osteoclasts increased Notum protein level but decreased β-catenin level, which is enhanced by IL-1β but is reversed by GW4869, QGY, and N-QGY (p < 0.05). And the effect of N-QGY is more conspicuous than that of QGY (P<0.05). N-QGY-containing serum inhibits exosome levels in osteoclasts, thereby enhancing osteogenic differentiation of MSCs via inhibition of Notum protein and promotion of β-catenin protein.</p>","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141465506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic Review and Phenome-Wide Scans of Genetic Associations with Vascular Cognitive Impairment 血管性认知障碍遗传关联的系统性回顾和全局扫描
IF 3.2 3区 生物学 Q3 MATERIALS SCIENCE, BIOMATERIALS Pub Date : 2024-06-27 DOI: 10.1002/adbi.202300692
Rime Diany, Sarah A Gagliano Taliun

Vascular cognitive impairment (VCI) is a heterogenous form of cognitive impairment that results from cerebrovascular disease. It is a result of both genetic and non-genetic factors. Although much research has been conducted on the genetic contributors to other forms of cognitive impairment (e.g. Alzheimer's disease), knowledge is lacking on the genetic factors associated with VCI. A better understanding of the genetics of VCI will be critical for prevention and treatment. To begin to fill this gap, the genetic contributors are reviewed with VCI from the literature. Phenome-wide scans of the identified genes are conducted and genetic variants identified in the review in large-scale resources displaying genetic variant-trait association information. Gene set are also carried out enrichment analysis using the genes identified from the review. Thirty one articles are identified meeting the search criteria and filters, from which 107 unique protein-coding genes are noted related to VCI. The phenome-wide scans and gene set enrichment analysis identify pathways associated with a diverse set of biological systems. This results indicate that genes with evidence of involvement in VCI are involved in a diverse set of biological functions. This information can facilitate downstream research to better dissect possible shared biological mechanisms for future therapies.

血管性认知障碍(VCI)是一种由脑血管疾病导致的异质性认知障碍。它是遗传和非遗传因素共同作用的结果。虽然对其他形式的认知障碍(如阿尔茨海默病)的遗传因素进行了大量研究,但对与血管性认知障碍相关的遗传因素却缺乏了解。更好地了解 VCI 的遗传因素对于预防和治疗至关重要。为了填补这一空白,我们从文献中回顾了与 VCI 相关的遗传因素。对确定的基因进行全表型扫描,并在显示遗传变异与性状关联信息的大型资源中对审查中确定的遗传变异进行分析。此外,还利用从综述中识别出的基因对基因集进行了富集分析。符合搜索标准和筛选条件的文章有 31 篇,其中有 107 个独特的蛋白编码基因与 VCI 有关。全表型扫描和基因组富集分析确定了与不同生物系统相关的通路。这一结果表明,有证据表明与 VCI 有关的基因参与了一系列不同的生物功能。这些信息可促进下游研究,更好地剖析可能的共同生物机制,为未来的疗法提供依据。
{"title":"Systematic Review and Phenome-Wide Scans of Genetic Associations with Vascular Cognitive Impairment","authors":"Rime Diany,&nbsp;Sarah A Gagliano Taliun","doi":"10.1002/adbi.202300692","DOIUrl":"10.1002/adbi.202300692","url":null,"abstract":"<p>Vascular cognitive impairment (VCI) is a heterogenous form of cognitive impairment that results from cerebrovascular disease. It is a result of both genetic and non-genetic factors. Although much research has been conducted on the genetic contributors to other forms of cognitive impairment (e.g. Alzheimer's disease), knowledge is lacking on the genetic factors associated with VCI. A better understanding of the genetics of VCI will be critical for prevention and treatment. To begin to fill this gap, the genetic contributors are reviewed with VCI from the literature. Phenome-wide scans of the identified genes are conducted and genetic variants identified in the review in large-scale resources displaying genetic variant-trait association information. Gene set are also carried out enrichment analysis using the genes identified from the review. Thirty one articles are identified meeting the search criteria and filters, from which 107 unique protein-coding genes are noted related to VCI. The phenome-wide scans and gene set enrichment analysis identify pathways associated with a diverse set of biological systems. This results indicate that genes with evidence of involvement in VCI are involved in a diverse set of biological functions. This information can facilitate downstream research to better dissect possible shared biological mechanisms for future therapies.</p>","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adbi.202300692","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141465507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging Life Sciences Series: Q&A with the Editor: Artificial Biology – Assemble, Imitate, Adapt 新兴生命科学系列:编辑问答:人工生物学--组装、模仿、适应。
IF 3.2 3区 生物学 Q3 MATERIALS SCIENCE, BIOMATERIALS Pub Date : 2024-06-25 DOI: 10.1002/adbi.202400256
<p><b>Städler</b>: I became fascinated with the hierarchical structure of mammalian cells when writing my postdoc fellowship application back in 2007. At that point, encapsulated catalysis existed, but sub-compartmentalization was a very new concept. We invented capsosomes (liposomes as subunits in polymer multilayer capsules), a very simple artificial cell, especially when looking back. When I started my independent research group in Denmark, the question was never IF we will be working in the area of artificial biology, more WHICH of the many aspects, we will be focusing on. For me, the most fascinating questions were and remain around considerations of how to integrate a bottom-up assembled life-like unit with living mammalian cells.</p><p><b>Valero</b>: I have always been fascinated by how biological systems work. For a chemist, a cell is a paradigm of complexity, where highly efficient reactions, molecular interactions, self-assembly, nanomechanics, directional transport, etc., harmoniously converge in a single entity. Inspired by Richard Feynman's quote: “What I cannot create, I do not understand,” my approach to biological systems involves developing artificial prototypes based on nucleic acid building blocks that mimic the structures and functions displayed in nature. These artificial molecules not only contribute to shedding light on how biological systems work, but they can also exhibit novel and enhanced functionalities that can be integrated to create unique synthetic biology systems or used for biomedical applications.</p><p><b>Zelikin</b>: I am teaching medicinal chemistry and through this, I gained an understanding and appreciation of the molecular composition of a cell; it inspired me, and challenged me to pursue this elegance and complexity of composition via the bottom-up approach, using in-house made molecules.</p><p><b>Sanchez</b>: There are a few reasons: I always loved the idea of reproducing the complexity of living systems by engineering something with our own hands, trying to mimic at least one of the hallmarks of life. For instance, in our lab, we focus on motion, from single to collective phenomena. And I still want to combine these artificial systems with living/biological components, such as cells or enzymes. That is what we call hybrid systems.</p><p><b>Sanchez</b>: Definitely nanomedicine. With the combination of artificial and biological components, we can design better delivery vehicles that interact more efficiently with biological systems and biomaterials such as cells and tumors.</p><p><b>Valero</b>: I believe integration and adaptation to living organisms are key for the advancement of the field. We need to develop artificial systems that do not merely work in parallel but rather integrate with cells, tissues, and organs, offering feedback communication and the capability of adapting to their environment and physicochemical signaling. An advanced feature of future synthetic biology systems will be to combine t
生物伦理学和宗教科学专家。如果人工生物学的概念最终被考虑应用于临床,病人的看法将非常重要,而自我维持甚至自我复制的系统将引起伦理方面的关注:Städler:我的目标是在同一特刊中收集来自人工生物学不同领域的投稿,以说明该领域的跨学科性质。对我来说,如果我们能够吸引来自世界各地的研究小组、多年来取得成功的实验室以及将塑造科学未来的年轻研究小组带头人投稿,这期特刊就成功了:我们正试图建立一个社区,相互承认并建立合作伙伴关系,当然也要把这一科学领域展示为一门成熟的学科,它对其他学科有很多贡献。安德森:我们的目标是通过聚集不同学科的研究人员,分享他们最近在人工生物学领域的研究成果,来激励人工生物学研究。人工生物学是一个雄心勃勃的未来研究领域,旨在设计出类似生命的系统,并开发出新颖的技术解决方案。桑切斯:我希望能有更多关于纳米电机如何在生物医学应用领域取得进展的文章。此外,我还希望能看到一些稿件从根本上报道具有新功能、生物兼容材料或新推进机制的新型人工系统的构建:我对这本特刊的主要期望是汇集该领域的最新投稿,包括有可能发展和超越到其他研究领域的作品,同时也能影响和启发其他科学家。理想情况下,该特刊将涵盖人工生物学最重要的趋势和未来方向,为该领域的下一步发展提供共同基础。ZelikinDepartment of Chemistry, Aarhus University, Aarhus, DenmarkAssociate Professor Ebbe Sloth AndersenInterdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, DenmarkProfessor Samuel Sánchez OrdóñezInstitute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Barcelona, SpainInstitució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain
{"title":"Emerging Life Sciences Series: Q&A with the Editor: Artificial Biology – Assemble, Imitate, Adapt","authors":"","doi":"10.1002/adbi.202400256","DOIUrl":"10.1002/adbi.202400256","url":null,"abstract":"&lt;p&gt;&lt;b&gt;Städler&lt;/b&gt;: I became fascinated with the hierarchical structure of mammalian cells when writing my postdoc fellowship application back in 2007. At that point, encapsulated catalysis existed, but sub-compartmentalization was a very new concept. We invented capsosomes (liposomes as subunits in polymer multilayer capsules), a very simple artificial cell, especially when looking back. When I started my independent research group in Denmark, the question was never IF we will be working in the area of artificial biology, more WHICH of the many aspects, we will be focusing on. For me, the most fascinating questions were and remain around considerations of how to integrate a bottom-up assembled life-like unit with living mammalian cells.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Valero&lt;/b&gt;: I have always been fascinated by how biological systems work. For a chemist, a cell is a paradigm of complexity, where highly efficient reactions, molecular interactions, self-assembly, nanomechanics, directional transport, etc., harmoniously converge in a single entity. Inspired by Richard Feynman's quote: “What I cannot create, I do not understand,” my approach to biological systems involves developing artificial prototypes based on nucleic acid building blocks that mimic the structures and functions displayed in nature. These artificial molecules not only contribute to shedding light on how biological systems work, but they can also exhibit novel and enhanced functionalities that can be integrated to create unique synthetic biology systems or used for biomedical applications.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Zelikin&lt;/b&gt;: I am teaching medicinal chemistry and through this, I gained an understanding and appreciation of the molecular composition of a cell; it inspired me, and challenged me to pursue this elegance and complexity of composition via the bottom-up approach, using in-house made molecules.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Sanchez&lt;/b&gt;: There are a few reasons: I always loved the idea of reproducing the complexity of living systems by engineering something with our own hands, trying to mimic at least one of the hallmarks of life. For instance, in our lab, we focus on motion, from single to collective phenomena. And I still want to combine these artificial systems with living/biological components, such as cells or enzymes. That is what we call hybrid systems.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Sanchez&lt;/b&gt;: Definitely nanomedicine. With the combination of artificial and biological components, we can design better delivery vehicles that interact more efficiently with biological systems and biomaterials such as cells and tumors.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Valero&lt;/b&gt;: I believe integration and adaptation to living organisms are key for the advancement of the field. We need to develop artificial systems that do not merely work in parallel but rather integrate with cells, tissues, and organs, offering feedback communication and the capability of adapting to their environment and physicochemical signaling. An advanced feature of future synthetic biology systems will be to combine t","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adbi.202400256","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141454603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
STL Inhibited Angiogenesis of DPSCs Through Depressing Mitochondrial Respiration by Enhancing RNF217 STL 通过增强 RNF217 来抑制线粒体呼吸,从而抑制 DPSCs 的血管生成。
IF 3.2 3区 生物学 Q3 MATERIALS SCIENCE, BIOMATERIALS Pub Date : 2024-06-16 DOI: 10.1002/adbi.202400042
Wanqing Wang, Haoqing Yang, Zhipeng Fan, Ruitang Shi

Angiogenesis is the determining factor during dental pulp regeneration. Six-twelve leukemia (STL) is identified as a key regulatory factor on the biological function of dental pulp stem cells (DPSCs) under hypoxic conditions, but its effect on angiogenesis is unclear. Co-culture of DPSCs and human umbilical vein endothelial cells (HUVECs) is used to detect tubule formation ability in vitro and the angiogenesis ability in vivo. RNA-seq and bioinformatic analyses are performed to screen differentially expressed genes. Seahorse Cell Mito Stress Test is proceeded to exam mitochondrial respiration. STL decreased tubule formation and mitochondrial respiration of DPSCs in vitro and restrained the number of blood vessels and the expression of VEGF in new formed tissue in vivo. Furthermore, pretreating STL-depleted DPSCs with rotenone, a mitochondrial respiration inhibitor, counteracted the promoting effect of STL knockdown on tubule formation. Then, RNA-seq and bioinformatic analyses identified some angiogenesis relevant genes and pathways in STL-depleted DPSCs. And STL enhanced expression of mRNA-ring finger protein 217 (RNF217), which inhibited the tubule formation and mitochondrial respiration of DPSCs. STL inhibited the angiogenesis of DPSCs through depressing mitochondrial respiration by enhancing RNF217, indicating that STL is a potential target for angiogenesis of DPSCs.

血管生成是牙髓再生过程中的决定性因素。六-十二白血病(STL)被认为是缺氧条件下牙髓干细胞(DPSCs)生物功能的关键调节因子,但其对血管生成的影响尚不清楚。本研究采用牙髓干细胞与人脐静脉内皮细胞(HUVECs)共培养的方法来检测体外小管形成能力和体内血管生成能力。通过 RNA-seq 和生物信息学分析筛选差异表达基因。海马细胞线粒体应激试验用于检测线粒体呼吸。STL 在体外减少了 DPSCs 的小管形成和线粒体呼吸,在体内抑制了血管数量和新形成组织中 VEGF 的表达。此外,用线粒体呼吸抑制剂鱼藤酮预处理 STL 缺失的 DPSCs 可抵消 STL 敲除对小管形成的促进作用。然后,RNA-seq和生物信息学分析确定了STL去势DPSCs中一些血管生成相关基因和通路。STL增强了mRNA-环指蛋白217(RNF217)的表达,而RNF217抑制了DPSCs的小管形成和线粒体呼吸。STL通过增强RNF217抑制线粒体呼吸来抑制DPSCs的血管生成,表明STL是DPSCs血管生成的潜在靶点。
{"title":"STL Inhibited Angiogenesis of DPSCs Through Depressing Mitochondrial Respiration by Enhancing RNF217","authors":"Wanqing Wang,&nbsp;Haoqing Yang,&nbsp;Zhipeng Fan,&nbsp;Ruitang Shi","doi":"10.1002/adbi.202400042","DOIUrl":"10.1002/adbi.202400042","url":null,"abstract":"<p>Angiogenesis is the determining factor during dental pulp regeneration. Six-twelve leukemia (STL) is identified as a key regulatory factor on the biological function of dental pulp stem cells (DPSCs) under hypoxic conditions, but its effect on angiogenesis is unclear. Co-culture of DPSCs and human umbilical vein endothelial cells (HUVECs) is used to detect tubule formation ability in vitro and the angiogenesis ability in vivo. RNA-seq and bioinformatic analyses are performed to screen differentially expressed genes. Seahorse Cell Mito Stress Test is proceeded to exam mitochondrial respiration. STL decreased tubule formation and mitochondrial respiration of DPSCs in vitro and restrained the number of blood vessels and the expression of VEGF in new formed tissue in vivo. Furthermore, pretreating STL-depleted DPSCs with rotenone, a mitochondrial respiration inhibitor, counteracted the promoting effect of STL knockdown on tubule formation. Then, RNA-seq and bioinformatic analyses identified some angiogenesis relevant genes and pathways in STL-depleted DPSCs. And STL enhanced expression of mRNA-ring finger protein 217 (RNF217), which inhibited the tubule formation and mitochondrial respiration of DPSCs. STL inhibited the angiogenesis of DPSCs through depressing mitochondrial respiration by enhancing RNF217, indicating that STL is a potential target for angiogenesis of DPSCs.</p>","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adbi.202400042","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanistic Characterization of De Novo Generation of Variable Number Tandem Repeats in Circular Plasmids during Site-Directed Mutagenesis and Optimization for Coding Gene Application 在定点突变过程中从新生成环状质粒中可变数目串联重复序列的机制特征及编码基因应用优化。
IF 3.2 3区 生物学 Q3 MATERIALS SCIENCE, BIOMATERIALS Pub Date : 2024-06-16 DOI: 10.1002/adbi.202400084
Ziqi Hu, Guochao Lin, Mingzhu Zhang, Shengwen Piao, Jiankun Fan, Jichao Liu, Peng Liu, Songbin Fu, Wenjing Sun, Li Li, Xiaohong Qiu, Jinwei Zhang, Yu Yang, Chunshui Zhou

Site-directed mutagenesis for creating point mutations, sometimes, gives rise to plasmids carrying variable number tandem repeats (VNTRs) locally, which are arbitrarily regarded as polymerase chain reaction (PCR) related artifacts. Here, the alternative end-joining mechanism is reported rather than PCR artifacts accounts largely for that VNTRs formation and expansion. During generating a point mutation on GPLD1 gene, an unexpected formation of VNTRs employing the 31 bp mutagenesis primers is observed as the repeat unit in the pcDNA3.1-GPLD1 plasmid. The 31 bp VNTRs are formed in 24.75% of the resulting clones with copy number varied from 2 to 13. All repeat units are aligned with the same orientation as GPLD1 gene. 43.54% of the repeat junctions harbor nucleotide mutations while the rest don't. Their demonstrated short primers spanning the 3′ part of the mutagenesis primers are essential for initial creation of the 2-copy tandem repeats (TRs) in circular plasmids. The dimerization of mutagenesis primers by the alternative end-joining in a correct orientation is required for further expansion of the 2-copy TRs. Lastly, a half-double priming strategy is established, verified the findings and offered a simple method for VNTRs creation on coding genes in circular plasmids without junction mutations.

为产生点突变而进行的定点突变有时会导致质粒局部携带可变数目串联重复序列(VNTR),这被武断地视为与聚合酶链式反应(PCR)有关的人工制品。这里报告的是另一种末端连接机制,而不是 PCR 伪影在很大程度上导致了 VNTR 的形成和扩展。在生成 GPLD1 基因点突变的过程中,使用 31 bp 诱变引物作为 pcDNA3.1-GPLD1 质粒中的重复单元,意外地观察到了 VNTRs 的形成。在 24.75% 的克隆中形成了 31 bp VNTR,其拷贝数从 2 个到 13 个不等。所有重复单元都与 GPLD1 基因的方向一致。43.54%的重复连接点存在核苷酸突变,其余的则没有。他们证明,诱变引物 3' 部分的短引物对于环状质粒中 2 个拷贝串联重复序列(TR)的初始创建至关重要。诱变引物在正确方向上的另类末端连接二聚化是进一步扩增双拷贝 TRs 所必需的。最后,建立了一种半双引物策略,验证了研究结果,并为在环状质粒编码基因上创建无连接突变的 VNTR 提供了一种简单的方法。
{"title":"Mechanistic Characterization of De Novo Generation of Variable Number Tandem Repeats in Circular Plasmids during Site-Directed Mutagenesis and Optimization for Coding Gene Application","authors":"Ziqi Hu,&nbsp;Guochao Lin,&nbsp;Mingzhu Zhang,&nbsp;Shengwen Piao,&nbsp;Jiankun Fan,&nbsp;Jichao Liu,&nbsp;Peng Liu,&nbsp;Songbin Fu,&nbsp;Wenjing Sun,&nbsp;Li Li,&nbsp;Xiaohong Qiu,&nbsp;Jinwei Zhang,&nbsp;Yu Yang,&nbsp;Chunshui Zhou","doi":"10.1002/adbi.202400084","DOIUrl":"10.1002/adbi.202400084","url":null,"abstract":"<p>Site-directed mutagenesis for creating point mutations, sometimes, gives rise to plasmids carrying variable number tandem repeats (VNTRs) locally, which are arbitrarily regarded as polymerase chain reaction (PCR) related artifacts. Here, the alternative end-joining mechanism is reported rather than PCR artifacts accounts largely for that VNTRs formation and expansion. During generating a point mutation on GPLD1 gene, an unexpected formation of VNTRs employing the 31 bp mutagenesis primers is observed as the repeat unit in the pcDNA3.1-GPLD1 plasmid. The 31 bp VNTRs are formed in 24.75% of the resulting clones with copy number varied from 2 to 13. All repeat units are aligned with the same orientation as GPLD1 gene. 43.54% of the repeat junctions harbor nucleotide mutations while the rest don't. Their demonstrated short primers spanning the 3′ part of the mutagenesis primers are essential for initial creation of the 2-copy tandem repeats (TRs) in circular plasmids. The dimerization of mutagenesis primers by the alternative end-joining in a correct orientation is required for further expansion of the 2-copy TRs. Lastly, a half-double priming strategy is established, verified the findings and offered a simple method for VNTRs creation on coding genes in circular plasmids without junction mutations.</p>","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mammal Aging as a Programmed Life Cycle Function – Resolving the Cause and Effect Conundrum 哺乳动物的衰老是一种程序化的生命周期功能--解决因果难题。
IF 3.2 3区 生物学 Q3 MATERIALS SCIENCE, BIOMATERIALS Pub Date : 2024-06-16 DOI: 10.1002/adbi.202300658
Theodore C. Goldsmith

Because aging and internally determined lifespan vary greatly between similar species it is now widely accepted that aging is an evolved trait, resulting in two classes of evolutionary aging theories: aging is programmed by complex biological mechanisms, and aging is not programmed. As recently as 2002 programmed aging is thought to be theoretically impossible. However, genetics discoveries, results of selective breeding, and other direct evidence strongly support the idea that aging creates an evolutionary advantage and that therefore complex biological mechanisms evolved that control aging in mammals and other multiparous organisms. Like life-cycle programs that control reproduction, growth, and menopause the aging program can adjust the aging trait during an individual's life to compensate for temporary or local changes in external conditions that alter the optimum lifespan for a particular species population. Genetics discoveries also strongly support the evolvability concept to the effect that sexually reproducing species can evolve design features that increase their ability to evolve, and that aging is one such feature. Genetics discoveries also prove that biological inheritance involves transmission of organism design information in digital form between parent and descendant of any organism. This has major implications for the evolution process.

由于衰老和由内部决定的寿命在同类物种之间存在很大差异,现在人们普遍认为衰老是一种进化的特征,由此产生了两类进化衰老理论:衰老是由复杂的生物机制编程的,而衰老则不是编程的。早在 2002 年,人们就认为程序化衰老在理论上是不可能的。然而,遗传学的发现、选择性繁殖的结果以及其他直接证据有力地支持了这样一种观点,即衰老创造了一种进化优势,因此哺乳动物和其他多配偶生物进化出了控制衰老的复杂生物机制。与控制繁殖、生长和绝经的生命周期程序一样,衰老程序可以在个体生命过程中调整衰老特征,以补偿外部条件的暂时或局部变化,从而改变特定物种种群的最佳寿命。遗传学的发现也有力地支持了可进化性概念,即有性繁殖的物种可以进化出提高其进化能力的设计特征,衰老就是这样的特征之一。遗传学的发现还证明,生物遗传涉及任何生物的亲代和后代之间以数字形式传递生物设计信息。这对进化过程具有重大影响。
{"title":"Mammal Aging as a Programmed Life Cycle Function – Resolving the Cause and Effect Conundrum","authors":"Theodore C. Goldsmith","doi":"10.1002/adbi.202300658","DOIUrl":"10.1002/adbi.202300658","url":null,"abstract":"<p>Because aging and internally determined lifespan vary greatly between similar species it is now widely accepted that aging is an evolved trait, resulting in two classes of evolutionary aging theories: aging is programmed by complex biological mechanisms, and aging is not programmed. As recently as 2002 programmed aging is thought to be theoretically impossible. However, genetics discoveries, results of selective breeding, and other direct evidence strongly support the idea that aging creates an evolutionary advantage and that therefore complex biological mechanisms evolved that control aging in mammals and other multiparous organisms. Like life-cycle programs that control reproduction, growth, and menopause the aging program can adjust the aging trait during an individual's life to compensate for temporary or local changes in external conditions that alter the optimum lifespan for a particular species population. Genetics discoveries also strongly support the <i>evolvability</i> concept to the effect that sexually reproducing species can evolve design features that increase their ability to evolve, and that aging is one such feature. Genetics discoveries also prove that biological inheritance involves transmission of organism design information in <i>digital form</i> between parent and descendant of any organism. This has major implications for the evolution process.</p>","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141330088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tas1R3 Dependent and Independent Recognition of Sugars in the Urethra and the Role of Tuft Cells in this Process (Adv. Biology 6/2024) Tas1R3依赖和独立识别尿道中的糖类以及簇细胞在此过程中的作用(生物学进展 6/2024)
IF 4.1 3区 生物学 Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-06-14 DOI: 10.1002/adbi.202470061
Patricia Schmidt, Alexander Perniss, Martin Bodenbenner-Tuerich, Silke Wiegand, Loic Briand, Klaus Deckmann

Urinary Tract Infection

Increased sugar concentrations display risk factors for infections. Article number 2400117 by Klaus Deckmann and co-workers clarifies sugar monitoring in the urethra. Urethral tuft cells (UTC) are sentinels monitoring the urethral lumen and initiating protective mechanisms. Monitoring occurs via two pathways. A UTC/Tas1R3 dependent and a Tas1R3 independent pathway, found in both UTC and in other urethral epithelial cells. Sugars increases detrusor muscle activity UTC/Tas1R3 dependently.

尿路感染糖浓度升高显示出感染的危险因素。克劳斯-德克曼(Klaus Deckmann)及其合作者撰写的编号为 2400117 的文章阐明了尿道中的糖监测。尿道丛细胞(UTC)是监测尿道腔和启动保护机制的哨兵。监测通过两条途径进行。一种是依赖UTC/Tas1R3的途径,另一种是独立于Tas1R3的途径,在UTC和其他尿道上皮细胞中均可发现。糖类会增加UTC/Tas1R3 依赖性的逼尿肌活动。
{"title":"Tas1R3 Dependent and Independent Recognition of Sugars in the Urethra and the Role of Tuft Cells in this Process (Adv. Biology 6/2024)","authors":"Patricia Schmidt,&nbsp;Alexander Perniss,&nbsp;Martin Bodenbenner-Tuerich,&nbsp;Silke Wiegand,&nbsp;Loic Briand,&nbsp;Klaus Deckmann","doi":"10.1002/adbi.202470061","DOIUrl":"https://doi.org/10.1002/adbi.202470061","url":null,"abstract":"<p><b>Urinary Tract Infection</b></p><p>Increased sugar concentrations display risk factors for infections. Article number 2400117 by Klaus Deckmann and co-workers clarifies sugar monitoring in the urethra. Urethral tuft cells (UTC) are sentinels monitoring the urethral lumen and initiating protective mechanisms. Monitoring occurs via two pathways. A UTC/Tas1R3 dependent and a Tas1R3 independent pathway, found in both UTC and in other urethral epithelial cells. Sugars increases detrusor muscle activity UTC/Tas1R3 dependently.\u0000\u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure></p>","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adbi.202470061","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141326709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Masthead: (Adv. Biology 6/2024) 刊头:(高级生物学 6/2024)
IF 4.1 3区 生物学 Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-06-14 DOI: 10.1002/adbi.202470062
{"title":"Masthead: (Adv. Biology 6/2024)","authors":"","doi":"10.1002/adbi.202470062","DOIUrl":"https://doi.org/10.1002/adbi.202470062","url":null,"abstract":"","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adbi.202470062","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141326708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deciphering the Drug Delivery Potential of Milk Exosome Nanovesicles for Aminobenzylpenicillin Therapeutic Efficacy against Contagious Staphylococcus Aureus in Bovine Mastitis (Adv. Biology 6/2024) 破译牛奶外泌体纳米微粒对氨苄青霉素治疗牛乳腺炎传染性金黄色葡萄球菌的给药潜力(生物学进展 6/2024)
IF 4.1 3区 生物学 Q1 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-06-14 DOI: 10.1002/adbi.202470063
Jitendra Kumar, Suneel Kumar Onteru, Dheer Singh

Staphylococcus Aureus

Treating contagious Staphylococcus aureus, the causative agent of bovine mastitis, is challenging with conventional antibiotics. In article number 2300519, Jitendra Kumar, Suneel Kumar Onteru, and Dheer Singh conduct cutting-edge research to deliver aminobenzylpenicillin into the mammary gland by harnessing the drug delivery potential of milk exosome nanovesicles. The advanced nanosystem demonstrate markedly superior therapeutic effectiveness compared to aminobenzylpenicillin when administered at the same dosage and treatment intervals, as illustrated on the cover page detailing the nanosystem.

金黄色葡萄球菌治疗传染性金黄色葡萄球菌是牛乳腺炎的致病菌,使用传统抗生素具有挑战性。在编号为 2300519 的文章中,Jitendra Kumar、Suneel Kumar Onteru 和 Dheer Singh 开展了前沿研究,利用牛奶外泌体纳米颗粒的给药潜力将氨苄青霉素送入乳腺。与氨苄青霉素相比,这种先进的纳米系统在相同剂量和治疗间隔的情况下显示出明显的治疗效果,详情请参见纳米系统的封面。
{"title":"Deciphering the Drug Delivery Potential of Milk Exosome Nanovesicles for Aminobenzylpenicillin Therapeutic Efficacy against Contagious Staphylococcus Aureus in Bovine Mastitis (Adv. Biology 6/2024)","authors":"Jitendra Kumar,&nbsp;Suneel Kumar Onteru,&nbsp;Dheer Singh","doi":"10.1002/adbi.202470063","DOIUrl":"https://doi.org/10.1002/adbi.202470063","url":null,"abstract":"<p><b><i>Staphylococcus Aureus</i></b></p><p>Treating contagious <i>Staphylococcus aureus</i>, the causative agent of bovine mastitis, is challenging with conventional antibiotics. In article number 2300519, Jitendra Kumar, Suneel Kumar Onteru, and Dheer Singh conduct cutting-edge research to deliver aminobenzylpenicillin into the mammary gland by harnessing the drug delivery potential of milk exosome nanovesicles. The advanced nanosystem demonstrate markedly superior therapeutic effectiveness compared to aminobenzylpenicillin when administered at the same dosage and treatment intervals, as illustrated on the cover page detailing the nanosystem.\u0000\u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure></p>","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":4.1,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adbi.202470063","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141326707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a Mouse Cardiac Sarcoidosis Model Using Carbon Nanotubes 利用碳纳米管开发小鼠心脏肉样瘤病模型
IF 3.2 3区 生物学 Q3 MATERIALS SCIENCE, BIOMATERIALS Pub Date : 2024-06-12 DOI: 10.1002/adbi.202400238
Sophie Van Remortel, Yousef Risha, Sandrine Parent, Vidhya Nair, David H. Birnie, Darryl R. Davis

Sarcoidosis, a granulomatous disorder of unknown etiology affecting multiple organs. It is often a benign disease but can have significant morbidity and mortality when the heart is involved (often presenting with clinical manifestations such as conduction irregularities and heart failure). This study addresses a critical gap in cardiac sarcoidosis (CS) research by developing a robust animal model. The absence of a reliable animal model for cardiac sarcoidosis is a significant obstacle in advancing understanding and treatment of this condition. The proposed model utilizes carbon nanotube injection and transverse aortic constriction as stressors. Intramyocardial injection of carbon nanotubes induces histiocytes typical of sarcoid granulomas in the heart but shows limited effects on fibrosis or cardiac function. Priming the immune system with transverse aortic constriction prior to intramyocardial injection of carbon nanotubes enhances cardiac fibrosis, diminishes cardiac function, and impairs cardiac conduction. This novel, easily executable model may serve as a valuable tool for disease profiling, biomarker identification, and therapeutic exploration.

肉样瘤病是一种病因不明的肉芽肿性疾病,影响多个器官。它通常是一种良性疾病,但如果累及心脏(通常表现为传导不规则和心力衰竭等临床表现),则会导致严重的发病率和死亡率。本研究通过建立一个强大的动物模型,填补了心脏肉样瘤病(CS)研究中的一个重要空白。心脏肉样瘤病缺乏可靠的动物模型,这严重阻碍了对该病的理解和治疗。拟议的模型利用碳纳米管注射和横向主动脉收缩作为应激源。心肌内注射碳纳米管可在心脏中诱导典型的肉芽肿组织细胞,但对纤维化或心脏功能的影响有限。在心肌内注射碳纳米管之前,先用横向主动脉收缩来激发免疫系统,可促进心脏纤维化、降低心脏功能并损害心脏传导。这种新颖、易于执行的模型可作为疾病分析、生物标记物鉴定和治疗探索的宝贵工具。
{"title":"Development of a Mouse Cardiac Sarcoidosis Model Using Carbon Nanotubes","authors":"Sophie Van Remortel,&nbsp;Yousef Risha,&nbsp;Sandrine Parent,&nbsp;Vidhya Nair,&nbsp;David H. Birnie,&nbsp;Darryl R. Davis","doi":"10.1002/adbi.202400238","DOIUrl":"10.1002/adbi.202400238","url":null,"abstract":"<p>Sarcoidosis, a granulomatous disorder of unknown etiology affecting multiple organs. It is often a benign disease but can have significant morbidity and mortality when the heart is involved (often presenting with clinical manifestations such as conduction irregularities and heart failure). This study addresses a critical gap in cardiac sarcoidosis (CS) research by developing a robust animal model. The absence of a reliable animal model for cardiac sarcoidosis is a significant obstacle in advancing understanding and treatment of this condition. The proposed model utilizes carbon nanotube injection and transverse aortic constriction as stressors. Intramyocardial injection of carbon nanotubes induces histiocytes typical of sarcoid granulomas in the heart but shows limited effects on fibrosis or cardiac function. Priming the immune system with transverse aortic constriction prior to intramyocardial injection of carbon nanotubes enhances cardiac fibrosis, diminishes cardiac function, and impairs cardiac conduction. This novel, easily executable model may serve as a valuable tool for disease profiling, biomarker identification, and therapeutic exploration.</p>","PeriodicalId":7234,"journal":{"name":"Advanced biology","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/adbi.202400238","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141305133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Advanced biology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1